Atsena Therapeutics has successfully closed an oversubscribed $150 million Series C financing round ...
read moreThe U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Aldeyra T...
read morePrevent Blindness, a leading nonprofit organization dedicated to eye health, has officially designat...
read moreLabtician Ophthalmics has officially announced the commercial launch of Lab TRIACTIV, a next-generat...
read moreZeiss Medical Technology has announced that ILM-Blue, an internal limiting membrane (ILM) dye develo...
read moreOKYO Pharma has announced encouraging data on the long-term stability of urcosimod (formerly OK-101)...
read moreSydnexis has announced a significant milestone with the European Medicines Agency’s (EMA) Committee ...
read moreAlcon has officially acquired a majority interest in Aurion Biotech, a clinical-stage biotech compan...
read moreBausch + Lomb has initiated a voluntary recall of specific intraocular lenses (IOLs) from its enVist...
read morePantheon Vision has announced a strategic partnership with Eyedeal Medical to co-develop a bioengine...
read more